Cargando…

Predicting chemotherapy‐induced menopause using baseline and post‐chemotherapy anti‐Müllerian hormone levels: Results of a pilot study

BACKGROUND: Chemotherapy can cause premature menopause which may result in adverse effects such as fertility loss, osteoporosis, cardiovascular disease and menopausal symptoms. It is thus very important that women are provided with accurate information regarding their risk of premature menopause as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martin, Hilary Laura, Ullah, Shahid, Abbas, Nazim, Scott‐Hoy, Alex, Kichenadasse, Ganessan, Karapetis, Christos Stelios, Roy, Amitesh, Sukumaran, Shawgi, Ross, David M, Khattak, Muhammad Adnan, Koczwara, Bogda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8222560/ https://www.ncbi.nlm.nih.gov/pubmed/33660428 http://dx.doi.org/10.1002/cnr2.1342

Ejemplares similares

Real‐world experience of nivolumab in the treatment of poor performance status patients with advanced non‐small cell lung cancer
por: Abbas, M. Nazim, et al.
Publicado: (2021)

Radiation Induced Leiomyosarcoma Three Decades After Treatment for Wilms’ Tumor
por: Khattak, Muhammad A, et al.
Publicado: (2010)

Pemetrexed-Induced Interstitial Pneumonitis: A Case Study and Literature Review
por: Waters, Michael J., et al.
Publicado: (2014)

Early tumor shrinkage identifies long-term disease control and survival in patients with lung cancer treated with atezolizumab
por: Hopkins, Ashley M, et al.
Publicado: (2020)

Serial monitoring of LV function following chemotherapy: assessment using advanced echocardiography and cardiovascular magnetic resonance
por: Grover, Suchi, et al.
Publicado: (2014)

The Influence of Pre-Existing Beta-Blockers Use on Survival Outcomes in HER2 Positive Advanced Breast Cancer: Pooled Analysis of Clinical Trial Data
por: Modi, Natansh D., et al.
Publicado: (2020)

Sorafenib-related generalized eruptive keratoacanthomas (Grzybowski syndrome): a case report
por: Abbas, M. Nazim, et al.
Publicado: (2021)

Association of BMI with overall survival in patients with mCRC who received chemotherapy versus EGFR and VEGF-targeted therapies
por: Patel, Gargi S, et al.
Publicado: (2015)

Reply: Comment on ‘Meta-analysis of BRAF mutation as a predictive biomarker of benefit from anti-EGFR monoclonal-antibody therapy for RAS wild-type metastatic colorectal cancer'
por: Rowland, Andrew, et al.
Publicado: (2015)

Phase I open-label trial of intraperitoneal paclitaxel in combination with intravenous cisplatin and oral capecitabine in patients with advanced gastric cancer and peritoneal metastases (IPGP study): study protocol
por: Vatandoust, Sina, et al.
Publicado: (2019)

The obesity paradox in early and advanced HER2 positive breast cancer: pooled analysis of clinical trial data
por: Modi, Natansh D., et al.
Publicado: (2021)

Targeted therapy for esophagogastric cancers: a review
por: Khattak, Muhammad A, et al.
Publicado: (2012)

Cardiotoxicity after cancer treatment: a process map of the patient treatment journey
por: Clark, Robyn A., et al.
Publicado: (2019)

Predicting response and toxicity to immune checkpoint inhibitors using routinely available blood and clinical markers
por: Hopkins, Ashley M, et al.
Publicado: (2017)

Feasibility, acceptability and preferences for intraperitoneal chemotherapy with paclitaxel and cisplatin after optimal debulking surgery for ovarian and related cancers: an ANZGOG study
por: Blinman, Prunella, et al.
Publicado: (2013)

Anti-Müllerian hormone (AMH) as a good predictor of time of menopause
por: Kruszyńska, Aleksandra, et al.
Publicado: (2017)

Anti-Müllerian hormone for the diagnosis and prediction of menopause: a systematic review
por: Nelson, Scott M, et al.
Publicado: (2023)

Amenorrhea and Menopause in Patients with Breast Cancer after Chemotherapy
por: Shin, Jae Jun, et al.
Publicado: (2019)

Contemporary breast cancer chemotherapy leads to persistent late right ventricular myocardial dysfunction: a prospective multi-centre study
por: Grover, Suchi, et al.
Publicado: (2013)

Post-chemotherapy serum anti-Müllerian hormone level predicts ovarian function recovery
por: Kim, Hyun-Ah, et al.
Publicado: (2018)

The Effects of Chemotherapy on the Levels of Serum Anti-Müllerian Hormone in Patients with Gestational Trophoblastic Neoplasia
por: Zamani, Mehrangiz, et al.
Publicado: (2023)

A Validated Model of Serum Anti-Müllerian Hormone from Conception to Menopause
por: Kelsey, Thomas W., et al.
Publicado: (2011)

Does the Anti-Mullerian Hormone Decline Rate Improve the Prediction of Age at Menopause?
por: Ramezani Tehrani, Fahimeh, et al.
Publicado: (2021)

Early and late left ventricular effects of breast cancer chemotherapy: a prospective multi-centre study using advanced cardiac imaging
por: Grover, Suchi, et al.
Publicado: (2013)

Rethinking cancer survivorship: the Prostate Cancer Survivorship Essentials Framework
por: Dunn, Jeff, et al.
Publicado: (2021)

Finding My Way from clinical trial to open access dissemination: comparison of uptake, adherence, and psychosocial outcomes of an online program for cancer-related distress
por: Beatty, Lisa, et al.
Publicado: (2022)

Shared care involving cancer specialists and primary care providers – What do cancer survivors want?
por: Lawn, Sharon, et al.
Publicado: (2017)

Health status and mental distress in people with cancer and comorbid conditions: The Australian National Health Survey analysis
por: Ng, Huah Shin, et al.
Publicado: (2023)

Predictors of anti-VEGF drug-induced hypertension using different hypertension criteria: a secondary analysis of the COMPARZ study
por: Mangoni, Arduino A., et al.
Publicado: (2018)

Early cardiac changes following anthracycline chemotherapy in breast cancer: a prospective multi-centre study using advanced cardiac imaging and biochemical markers
por: Grover, Suchi, et al.
Publicado: (2012)

Relationship of menopausal status and climacteric symptoms to sleep in women undergoing chemotherapy
por: Rissling, Michelle B., et al.
Publicado: (2010)

Implementing a web-based system of screening for symptoms and needs using patient-reported outcomes in people with cancer
por: Koczwara, Bogda, et al.
Publicado: (2022)

Incidence and Impact of Baseline Electrolyte Abnormalities in Patients Admitted with Chemotherapy Induced Febrile Neutropenia
por: Shaikh, Asim Jamal, et al.
Publicado: (2011)

Influence of menopause on chemotherapy‐induced nausea and vomiting in highly emetogenic chemotherapy for breast cancer: A retrospective observational study
por: Yokokawa, Takashi, et al.
Publicado: (2023)

Finding My Way: protocol of a randomised controlled trial evaluating an internet self-help program for cancer-related distress
por: Beatty, Lisa, et al.
Publicado: (2015)

Modality preferences for health behaviour interventions for post-treatment cancer survivors: a theoretical investigation
por: Leske, Morgan, et al.
Publicado: (2023)

Paclitaxel–ifosfamide–carboplatin combination chemotherapy regimen in advanced uterine and adnexal malignant mixed Mullerian tumours
por: Kosmas, C, et al.
Publicado: (2011)

Pretreatment anti-Müllerian hormone predicts for loss of ovarian function after chemotherapy for early breast cancer()
por: Anderson, Richard A., et al.
Publicado: (2013)

Age, anti-müllerian hormone, antral follicles count to predict amenorrhea or oligomenorrhea after chemotherapy with cyclophosphamide
por: D’Avila, Ângela Marcon, et al.
Publicado: (2015)

Conventional myelosuppressive chemotherapy for non-haematological malignancy disrupts the intestinal microbiome
por: Papanicolas, Lito E., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_uqqduq3r3e08vjr5dsndjpqfl4